Unlock instant, AI-driven research and patent intelligence for your innovation.

Cells, pancreatic islets, and organoids that evade immune detection and autoimmunity, methods of production and use thereof

A technology for immunological detection, autoimmunity, applied to rejection or autoimmunity. , the field of organ or islet-like organoids, which can solve the problems of immune system detection, injury, destruction, etc.

Pending Publication Date: 2021-10-01
SALK INST FOR BIOLOGICAL STUDIES
View PDF11 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Despite advances in the field of in vitro differentiation of human induced pluripotent stem cells (hiPSCs) into β-like cells, β-like cells generated in this manner often exhibit impaired glucose-stimulated insulin secretion (GSIS) and mitochondrial metabolic function. Injury, and detection and destruction of the recipient's immune system following administration

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cells, pancreatic islets, and organoids that evade immune detection and autoimmunity, methods of production and use thereof
  • Cells, pancreatic islets, and organoids that evade immune detection and autoimmunity, methods of production and use thereof
  • Cells, pancreatic islets, and organoids that evade immune detection and autoimmunity, methods of production and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0390] Example 1: Generation and Characterization of Pancreatic and Islet Organoids

[0391] Although animal disease models can provide insight into disease pathogenesis, drugs identified from screening using animal models often cannot be adopted in human patients. The generation of functional human organoids offers a new therapeutic strategy for drug screening and disease modeling. This article describes a technique to generate 3D human pancreatic mini-organs or organoids (e.g. HILO) in a dish. Using the described technique, diseases such as human type 2 diabetes can be modeled in vitro to find effective drugs against genetic, patient or environment specific diseases such as human type 2 diabetes.

[0392] Development of a gellan gum-based 3D culture system for β-like cell differentiation

[0393] 3-dimensional (3D) culture systems are known to help promote cell self-organization and integration. Therefore, containing extracellular matrix components such as collagen and fi...

Embodiment 2

[0407] Example 2: Transplanted functional islet organoids rescue type 1 diabetic mice

[0408] As further described in the Examples below, expression of specific functional islet markers such as MAFA, UCN3 and mitochondrial oxidation genes such as ERRγ (Esrrg), Ndufa1, Ndufa12 was observed in hiPSC-derived human islet-like organoids , Cox7a2 and Atp5b. Remarkably, these islet-like organoids were recaptured both in human islet development and in the pathogenesis of diabetes. Transplantation of these functional islet-like organoids rescued type 1 diabetic mice with long survival, rapid angiogenesis, and reduced immune rejection.

Embodiment 3

[0409] Example 3: Wnt proteins in metabolic maturation of islet organoids from iPSCs

[0410] Fltp and Esrrg genes were found to be expressed in iPSC-derived islet organoids after treatment with PBS, WNT3a (500 ng / ml), recombinant human (rh) WNT4 (100 ng / ml), or rhWNT5a (400 ng / ml) (day 21 , no need to co-culture with hADSCs or HUVECs). Response to increased rhWNT4 (0, 10, 25, 50, 100, 200 ng / ml) and rhWNT5a (0, 25, 50, 100, 200, 400 ng / ml). Furthermore, mitochondrial genes involved in oxidative phosphorylation (Cox7a2, Ndufa1, Ndufa7), lactate dehydrogenase (Ldha), and Fltp (Wnt / planar cell polarity (PCP) effector and reporter Gene). In the absence of supportive hADSC or HUVEC, should respond to increasing doses of rhWNT4 (0, 10, 25, 50, 100, 200 ng / ml) and rhWNT5a (0, 25, 50, 100, 200, 400 ng / ml). Mitochondria (Mitotracker; mitochondria red) and insulin (Insulin-GFP) levels were increased in hiPSC-derived islet organoids after treatment with PBS or WNT4 (100 ng / ml) for 8 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention features cells, islet-like cells, pancreatic islets and organoids (e.g., human islet-like organoids or HILOs), as well as cell cultures and methods that are useful for the rapid and reliable generation of cells and organoids, such as pancreatic islets and organoids, that are sustainable in vivo and that evade immune detection, rejection and autoimmunity. The invention also features methods of treating pancreatic diseases, such as type 2 diabetes, and pancreatic cancer, using the cells, islet-like cells, pancreatic islets and organoids (e.g., HILOs) that are designed to modulate the activity of immune cells that would otherwise react against them.

Description

[0001] This application claims priority to and the benefit of U.S. Provisional Application No. 62 / 795,284, filed January 22, 2019, and U.S. Provisional Application No. 62 / 745,086, filed October 12, 2018, the entire contents of which are incorporated herein by reference. [0002] Statement of Invention Rights under Commonwealth Supported Research [0003] This application was made with government support under NIH Grant Research Nos. DK057978, DK090962, HL088093, HL105278, and ES010337, and NIH and National Cancer Institute Grant Research No. P30 014195. The government owns certain rights in this application. Background technique [0004] For the treatment of insulin-dependent diabetes, such as type 1 diabetes and advanced type 2 diabetes, the shortage of human islets limits the number of patients who can benefit from the therapy. Despite advances in the field of in vitro differentiation of human induced pluripotent stem cells (hiPSCs) into β-like cells, β-like cells generated...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/17C12N5/095A61K38/19A61P37/06C12N5/074C12N5/0789
CPCA61P37/06A61K35/39C12N5/0677C12N2502/1382C12N2502/28C12N2506/45C12N2533/70C12N2510/00C12N2501/415C12N2533/90A61K38/217A61K35/28A61P3/10C12N2513/00
Inventor E·吉原R·于M·唐斯R·埃文斯A·阿特金斯
Owner SALK INST FOR BIOLOGICAL STUDIES